-
公开(公告)号:US11324766B2
公开(公告)日:2022-05-10
申请号:US17320003
申请日:2021-05-13
申请人: Glycosyn LLC
IPC分类号: A61K31/702 , A61K9/00 , A61K45/06 , A61K35/745 , A61K35/742 , A61K35/74 , A23L33/125 , A23L33/00 , A23L2/52 , A61K35/747
摘要: The invention provides compositions and methods for utilizing oligosaccharides, such as isolated human milk oligosaccharides, to attenuate a respiratory pathogen infection-induced host inflammation and/or to promote recovery from a respiratory pathogen infection-induced host inflammation in a subject.
-
2.
公开(公告)号:US20190255083A1
公开(公告)日:2019-08-22
申请号:US16403095
申请日:2019-05-03
摘要: The invention provides compositions and methods for utilizing synthetic human milk oligosaccharides as prebiotics.
-
3.
公开(公告)号:US20170136049A1
公开(公告)日:2017-05-18
申请号:US15419241
申请日:2017-01-30
IPC分类号: A61K31/702 , A23L2/52 , A23L33/00 , A23L33/10
CPC分类号: A61K31/702 , A23L2/52 , A23L33/10 , A23L33/21 , A23L33/28 , A23L33/40 , A23V2002/00 , C07H3/06 , Y02A50/473 , Y02A50/481
摘要: The invention provides compositions and methods for utilizing synthetic human milk oligosaccharides as prebiotics.
-
4.
公开(公告)号:US10286001B2
公开(公告)日:2019-05-14
申请号:US15419241
申请日:2017-01-30
摘要: The invention provides compositions and methods for utilizing synthetic human milk oligosaccharides as prebiotics.
-
公开(公告)号:US20210353654A1
公开(公告)日:2021-11-18
申请号:US17320152
申请日:2021-05-13
申请人: Glycosyn LLC
IPC分类号: A61K31/702 , A61P31/14 , A23L33/125 , A23C9/20
摘要: The invention provides compositions and methods for utilizing oligosaccharides, such as isolated human milk oligosaccharides, to attenuate a respiratory pathogen infection and/or to promote recovery from a respiratory pathogen infection in the respiratory system and/or the GI tract of a subject.
-
公开(公告)号:US11331329B2
公开(公告)日:2022-05-17
申请号:US17320152
申请日:2021-05-13
申请人: Glycosyn LLC
IPC分类号: A61K31/702 , A61P31/14 , A23C9/20 , A23L33/125
摘要: The invention provides compositions and methods for utilizing oligosaccharides, such as isolated human milk oligosaccharides, to attenuate a respiratory pathogen infection and/or to promote recovery from a respiratory pathogen infection in the respiratory system and/or the GI tract of a subject.
-
公开(公告)号:US20210353653A1
公开(公告)日:2021-11-18
申请号:US17320003
申请日:2021-05-13
申请人: Glycosyn LLC
IPC分类号: A61K31/702 , A61K9/00 , A61K45/06 , A61K35/745 , A61K35/747 , A61K35/742 , A61K35/74 , A23L33/125 , A23L33/00 , A23L2/52
摘要: The invention provides compositions and methods for utilizing oligosaccharides, such as isolated human milk oligosaccharides, to attenuate a respiratory pathogen infection-induced host inflammation and/or to promote recovery from a respiratory pathogen infection-induced host inflammation in a subject.
-
-
-
-
-
-